Switch theme
Sign up to access all valuation multiples
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
2021
111
LTM Revenue $13.5M
LTM EBITDA -$38.9M
$14.1M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Hyperfine has a last 12-month revenue (LTM) of $13.5M and a last 12-month EBITDA of -$38.9M.
In the most recent fiscal year, Hyperfine achieved revenue of $12.9M and an EBITDA of -$42.2M.
Hyperfine expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Hyperfine valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $13.5M | XXX | $12.9M | XXX | XXX | XXX |
| Gross Profit | $6.2M | XXX | $5.9M | XXX | XXX | XXX |
| Gross Margin | 46% | XXX | 46% | XXX | XXX | XXX |
| EBITDA | -$38.9M | XXX | -$42.2M | XXX | XXX | XXX |
| EBITDA Margin | -289% | XXX | -328% | XXX | XXX | XXX |
| EBIT | -$41.0M | XXX | -$43.2M | XXX | XXX | XXX |
| EBIT Margin | -304% | XXX | -335% | XXX | XXX | XXX |
| Net Profit | -$38.3M | XXX | -$40.7M | XXX | XXX | XXX |
| Net Margin | -284% | XXX | -316% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Hyperfine's stock price is $1.
Hyperfine has current market cap of $46.9M, and EV of $14.1M.
See Hyperfine trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $14.1M | $46.9M | XXX | XXX | XXX | XXX | $-0.52 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Hyperfine has market cap of $46.9M and EV of $14.1M.
Hyperfine's trades at 1.1x EV/Revenue multiple, and -0.3x EV/EBITDA.
Equity research analysts estimate Hyperfine's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Hyperfine has a P/E ratio of -1.2x.
See valuation multiples for Hyperfine and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $46.9M | XXX | $46.9M | XXX | XXX | XXX |
| EV (current) | $14.1M | XXX | $14.1M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | -0.4x | XXX | -0.3x | XXX | XXX | XXX |
| EV/EBIT | -0.3x | XXX | -0.3x | XXX | XXX | XXX |
| EV/Gross Profit | 2.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | -1.2x | XXX | -1.2x | XXX | XXX | XXX |
| EV/FCF | -0.3x | XXX | -0.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialHyperfine's last 12 month revenue growth is 17%
Hyperfine's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.4M for the same period.
Hyperfine's rule of 40 is -410% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Hyperfine's rule of X is -246% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Hyperfine and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 17% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | -289% | XXX | -328% | XXX | XXX | XXX |
| EBITDA Growth | -17% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -410% | XXX | -311% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -246% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 71% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 175% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 381% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Hyperfine acquired XXX companies to date.
Last acquisition by Hyperfine was XXXXXXXX, XXXXX XXXXX XXXXXX . Hyperfine acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Hyperfine founded? | Hyperfine was founded in 2021. |
| Where is Hyperfine headquartered? | Hyperfine is headquartered in United States of America. |
| How many employees does Hyperfine have? | As of today, Hyperfine has 111 employees. |
| Who is the CEO of Hyperfine? | Hyperfine's CEO is Ms. Maria Sainz. |
| Is Hyperfine publicy listed? | Yes, Hyperfine is a public company listed on NAS. |
| What is the stock symbol of Hyperfine? | Hyperfine trades under HYPR ticker. |
| When did Hyperfine go public? | Hyperfine went public in 2021. |
| Who are competitors of Hyperfine? | Similar companies to Hyperfine include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Hyperfine? | Hyperfine's current market cap is $46.9M |
| What is the current revenue of Hyperfine? | Hyperfine's last 12 months revenue is $13.5M. |
| What is the current revenue growth of Hyperfine? | Hyperfine revenue growth (NTM/LTM) is 17%. |
| What is the current EV/Revenue multiple of Hyperfine? | Current revenue multiple of Hyperfine is 1.0x. |
| Is Hyperfine profitable? | Yes, Hyperfine is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Hyperfine? | Hyperfine's last 12 months EBITDA is -$38.9M. |
| What is Hyperfine's EBITDA margin? | Hyperfine's last 12 months EBITDA margin is -289%. |
| What is the current EV/EBITDA multiple of Hyperfine? | Current EBITDA multiple of Hyperfine is -0.4x. |
| What is the current FCF of Hyperfine? | Hyperfine's last 12 months FCF is -$40.6M. |
| What is Hyperfine's FCF margin? | Hyperfine's last 12 months FCF margin is -301%. |
| What is the current EV/FCF multiple of Hyperfine? | Current FCF multiple of Hyperfine is -0.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
